Pfizer and BioNTech have announced that their vaccine candidate against COVID-19 achieved success in the first interim analysis from the phase 3 COVID-19 vaccine trial.
10th November 2020 •
comment
9th November 2020 •
comment
CONSIDERATIONS FOR EVALUATION OF COVID19 VACCINES
by World Health Organization
30th September 2020 •
comment